How could a Pharmaceutical company in the Phase I/II study be almost done with conversion, "Show Me The Money", where is the money going to come from for Phase III study and them submission to FDA for approval, to sell to public? I hope you are right, at this point without a joint-venture, how can this happen?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.